Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use

Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use

ST. LOUIS, Feb. 06, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that beginning Friday, April 5, 2024, Ioflupane I 123 Injection will be available for Friday patient administration in the US. This additional day of production allows customers to access the product and capitalize on early morning availability on … Read more

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

— Eton Cares patient support program offers $0 co-pay to eligible, commercially insured patients* —— Current Nitisinone market is estimated to exceed $50 million annually —— Product is now available exclusively through Optime Care — DEER PARK, Ill., Feb. 02, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical … Read more

DataParser releases FX Connect module in general availability

DataParser releases FX Connect module in general availability

NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) — DataParser has been developed to support collection of FX Connect data. FX Connect is State Street’s market-leading platform for FX execution, portfolio management and streamlined global operations. FX Connect simplifies and automates the entire FX trading process – from pre-trade through execution to post-trade settlement. DataParser is 17a-4’s leading … Read more